Investigation on the Epidemic Prevention Effect of Using Chinese Medicine During the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Outbreak.

Study Overview
=================
Brief Summary
-----------------
Taking a regional hospital as an example, the investigators will discuss the changes in the community cumulative incidence rate(CIR) and the epidemic prevention effect of using Chinese medicine during the SARS-CoV-2 outbreak. Main purpose: Retrospective case study to explore the effect of traditional Chinese medicine on the prevention of SARS-CoV-2. Secondary purpose: If there are related side effects after taking Chinese medicine.

Detailed Description
-----------------
The large-scale coronavirus epidemic is a major global public health challenge in the 21st century. Since the 2003 Severe acute respiratory syndrome (SARS) epidemic spread globally and caused hundreds of deaths, the Middle East respiratory syndrome (Middle East respiratory syndrome, MERS) and coronavirus disease 2019(COVID-19) has caused a large-scale global spread and also caused a huge impact on the public health and medical system. In the country's current epidemic (Aug 1, 2021), more than 15,000 people have been diagnosed, and the number of deaths has exceeded 800. Among them, the Taipei epidemic is the most severe, and the Wanhua District of Taipei City is the hot zone. The investigators will discuss the changes in accumulation incidence rate(CIR) of the community and the epidemic prevention effect of using Chinese medicine during the SARS-CoV-2 outbreak. This is a retrospective case study to explore the effect of traditional Chinese medicine on the prevention of SARS-CoV-2 and discuss if there are related side effects after taking Chinese medicine.

Official Title
-----------------
Taipei City Hospital Linsen Chinese Medicine and Kunming Branch

Conditions
-----------------
COVID-19 Pandemic

Intervention / Treatment
-----------------
* Drug: Jing-Guan-Fang(JGF) : Chinese herbal decoction


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: - From January 1, 2020 to July 31, 2021, Chinese medicine is used for patients with new coronary pneumonia epidemic prevention. Exclusion Criteria: Patients who do not use traditional Chinese medicine for the prevention of new coronary pneumonia. Patients who have signed and refused to provide medical records.
Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
Accepts Healthy Volunteers

Study Plan
=================
How is the study designed?
-----------------

Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| JGF (Jing-Guan-Fang): Traditional Chinese Medicine Decoction<br>JGF group: 100ml JGF decoction per day at least 1 week | Drug: Jing-Guan-Fang(JGF) : Chinese herbal decoction<br>* Use 100ml JGF decoction per day as a preventive measure for patients with COVID-19.<br>* Other names: Chinese herbal decoction;|
| NO JGF<br>NO JGF group: None use traditional Chinese medicine(JGF) | |

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Investigation on the effect of using traditional Chinese medicine to prevent SARS-CoV-2 infection in two groups with cumulative incidence rate(CIR). | Compare the dangerous states within two groups with CIR. | 18 months | 

 Terms related to the study
=================
Keywords Provided by Centre Hospitalier Valida
-----------------
Chinese medicine